Kun Qian Selected Research

glycyl- arginyl- glycyl- aspartyl- seryl- proline

6/2016

Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun Qian Research Topics

Disease

63	Neoplasms (Cancer) 09/2022 - 03/2005
31	Infections 05/2022 - 11/2010
14	Stomach Neoplasms (Stomach Cancer) 06/2021 - 03/2005
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2014
11	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2005
10	Virus Diseases (Viral Diseases) 01/2022 - 01/2009
9	Inflammation (Inflammations) 10/2021 - 12/2008
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2015
8	Atherosclerosis 01/2021 - 09/2004
7	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2007
7	Marek Disease (Marek's Disease) 01/2022 - 01/2009
7	Lung Neoplasms (Lung Cancer) 01/2021 - 04/2011
7	Hemorrhage 01/2021 - 10/2013
6	Carcinoma (Carcinomatosis) 11/2021 - 03/2005
5	Ischemia 10/2021 - 05/2002
5	Body Weight (Weight, Body) 04/2020 - 11/2006
5	Carcinogenesis 05/2018 - 01/2007
4	Influenza in Birds (Avian Flu) 01/2021 - 01/2009
4	Lymphatic Metastasis 05/2020 - 03/2005
3	Ovarian Neoplasms (Ovarian Cancer) 09/2022 - 06/2015
3	Adenocarcinoma of Lung 01/2022 - 08/2017
3	Infarction (Infarctions) 01/2022 - 01/2018
3	Necrosis 09/2021 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2018
3	Human Influenza (Influenza) 01/2021 - 05/2016
3	Liver Neoplasms (Liver Cancer) 01/2021 - 08/2015
3	Obesity 10/2020 - 03/2010
3	Portal Hypertension 09/2020 - 01/2020
3	Heart Failure 04/2020 - 01/2018
3	Leukemia 01/2020 - 03/2007
3	Insulin Resistance 01/2020 - 09/2015
3	Fibrosis (Cirrhosis) 11/2019 - 01/2018
3	Hypoxia (Hypoxemia) 01/2019 - 07/2003
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2022 - 10/2021
2	COVID-19 05/2022 - 11/2021
2	Arthritis (Polyarthritis) 05/2022 - 07/2017
2	Glaucoma 01/2022 - 10/2021
2	Ischemic Stroke 01/2022 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2016
2	Thrombosis (Thrombus) 01/2022 - 12/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2012
2	Photophobia (Light Sensitivity) 10/2021 - 02/2018
2	Schizophrenia (Dementia Praecox) 08/2021 - 01/2019
2	Hyperthermia 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
10	Biomarkers (Surrogate Marker)IBA 09/2022 - 03/2005
9	Messenger RNA (mRNA)IBA 05/2022 - 05/2002
7	Pharmaceutical PreparationsIBA 09/2022 - 11/2013
7	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 09/2004
6	EnzymesIBA 01/2022 - 09/2004
6	LigandsIBA 01/2020 - 03/2016
5	CytokinesIBA 04/2022 - 03/2007
5	Biological ProductsIBA 04/2022 - 01/2015
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2015
5	LipidsIBA 11/2021 - 09/2004
5	AntibodiesIBA 11/2021 - 01/2015
5	CholesterolIBA 01/2021 - 09/2004
4	Antiviral Agents (Antivirals)IBA 11/2021 - 01/2018
4	AntigensIBA 11/2021 - 09/2015
4	Tumor Biomarkers (Tumor Markers)IBA 11/2021 - 01/2007
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2016
4	RetinoidsIBA 06/2020 - 01/2018
4	Insulin (Novolin)FDA Link 01/2018 - 09/2004
4	Small Interfering RNA (siRNA)IBA 09/2016 - 01/2015
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
3	Antipsychotic Agents (Antipsychotics)IBA 08/2021 - 01/2019
3	4-phenylbutyric acid (Buphenyl)FDA Link 08/2021 - 05/2018
3	CateninsIBA 01/2021 - 01/2015
3	Silicon Dioxide (Silica)FDA LinkGeneric 12/2020 - 01/2018
3	Peptides (Polypeptides)IBA 09/2020 - 01/2018
3	Galectin 3 (LGALS3)IBA 05/2020 - 03/2005
3	PolymersIBA 01/2020 - 06/2018
3	Oncogene Proteins (Oncogene Protein)IBA 09/2016 - 01/2016
3	Lipase (Acid Lipase)FDA Link 03/2010 - 09/2004
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2009 - 01/2007
2	Metal-Organic FrameworksIBA 07/2022 - 01/2021
2	AutoantibodiesIBA 05/2022 - 11/2021
2	Green Fluorescent ProteinsIBA 04/2022 - 01/2009
2	CeriumIBA 01/2022 - 12/2021
2	ZeolitesIBA 01/2022 - 12/2021
2	VaccinesIBA 01/2022 - 01/2021
2	N-methyladenosineIBA 01/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021 - 10/2019
2	Volatile Fatty AcidsIBA 10/2021 - 01/2018
2	Olanzapine (Zyprexa)FDA Link 08/2021 - 01/2020
2	AlloysIBA 04/2021 - 06/2020
2	Hormones (Hormone)IBA 01/2021 - 01/2020
2	Liposomes (Liposome)IBA 01/2021 - 12/2020
2	IodineIBA 01/2021 - 01/2021

Therapy/Procedure

21	Therapeutics 06/2021 - 04/2007
11	Drug Therapy (Chemotherapy) 01/2022 - 01/2007
10	Radiofrequency Ablation 04/2021 - 04/2011
6	Precision Medicine 01/2022 - 01/2018
5	Radiotherapy 01/2021 - 01/2007
5	Transjugular Intrahepatic Portasystemic Shunt 09/2020 - 01/2017
4	Electrodes (Electrode) 04/2022 - 06/2017
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 09/2020 - 01/2020
2	Punctures 01/2021 - 01/2019